Takeda v Roche: "Is it plausible? Is it true?" By Dr Rose Hughes on Thursday, August 01, 2019 biologics biosimilars Entyvio insufficiency monoclonal antibody mr justice birss patents plausibility Roche Second medical use takeda Vedolizumab Warner-Lambert +
Roche shields itself from a UK Arrow: Pfizer v Roche By Dr Rose Hughes on Thursday, June 27, 2019 arrow declaration Arvastin bevacizumab biologics biosimilars monoclonal antibody mr justice birss patents pfizer Roche SPC +
Fordham 27 (Report 9): Biologics and Biosimilars By Annsley Merelle Ward on Sunday, April 28, 2019 #IPKat AmeriKat amgen v sanofi biologic launch biologics biosimilars BPCIA event report fordham 2019 humira injunctions launch psk9 +
Shall we dance? Regulatory approval, trade secrets and the transatlantic biosimilars patent wars By Annsley Merelle Ward on Sunday, March 12, 2017 AmeriKat biologics biosimilars BPCIA EFPIA fujifilm marketing authorisation patent litigation patent strategy regulatory approval regulatory data trade secrets us patent litigation +
Biosimilars and generics as "rip-offs": when the facts may not matter By Neil Wilkof on Friday, March 10, 2017 biosimilars Bloomberg confirmation bias Elisabeth Kolbert generics Gideon Parchomovsky Neil Wilkof Peter Siegelman Rashi +
Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans By Annsley Merelle Ward on Thursday, March 09, 2017 Alphabet AmeriKat amgen biosimilars confidential information Defend Trade Secrets Act pfizer theft of trade secrets trade secrets Uber +
Will the Arrow hit the Humira target? Find out tomorrow! By Annsley Merelle Ward on Thursday, March 02, 2017 AbbVie adalimumab AmeriKat Arrow declarations biosimilars clearing the path Court of Appeal fujifilm Mr Justice Arnold mr justice carr +
AIPPI Congress Report 3: Biosimilars – similar but different? By Annsley Merelle Ward on Friday, September 23, 2016 AIPPI Congress 2016 biosimilars biotech patent European patent litigation event report inter partes review Post grant review us patent litigation +